Trademark: XENADRINE CORE
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for XENADRINE CORE
We do not have any records of a proof of use for XENADRINE CORE at this moment.
Possible trademark infringements of XENADRINE CORE
Basic Information about XENADRINE CORE
- Serial Number
- 86392419
- Filing Date
- 11 Sep 2014
- Registration Number
- 4838037
- Registration Date
- 20 Oct 2015
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of XENADRINE CORE on the blockchain with WikiTrademarks.io.
- First use of XENADRINE CORE anywhere
- XENADRINE CORE was first used on 16 Sep 2014 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 2
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns XENADRINE CORE?
1. NORTHERN INNOVATIONS HOLDING CORP. Oakville, Ontario
2. NORTHERN INNOVATIONS HOLDING CORP. Oakville, Ontario
3. NORTHERN INNOVATIONS HOLDING CORP. Oakville, Ontario
Correspondent
- Douglas R. Wolf
- Wolf, Greenfield & Sacks, P.C.
- 600 Atlantic Avenue
- Boston MA 02210
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io